Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.1%

1 terminated/withdrawn out of 14 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
8(100.0%)
8Total
N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT03749343Active Not Recruiting

International T1 Multicenter Outcome Study

Role: collaborator

NCT07299227Recruiting

Impact of BPA in CTEPH on Cardiac and Pulmonary Physiology Assessed by CMR-derived 4D Flow Haemodynamics

Role: lead

NCT07018778Not Yet Recruiting

CMR-derived Quantitative Perfusion for Prediction of FFR

Role: lead

NCT05110066Not ApplicableRecruiting

BPA vs. PEA in CTEPH

Role: collaborator

NCT04265040Recruiting

DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies

Role: collaborator

NCT04630236Not ApplicableCompleted

Ultrasound Guided Positioning of Central Venous Catheters

Role: collaborator

NCT03021369Not ApplicableCompleted

Comparison of Two Different Pleural Drainage Systems

Role: lead

NCT03023475Not ApplicableCompleted

Comparison of Two Different Endoscopic Radial Artery Harvesting Devices

Role: lead

NCT04111744Not ApplicableCompleted

Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery

Role: lead

NCT02632292Not ApplicableTerminated

EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus

Role: collaborator

NCT03021356Not ApplicableCompleted

Comparison of TrIfecta and Perimount Magna Ease

Role: lead

NCT02187263Unknown

German Centre for Cardiovascular Research Cardiomyopathy Register

Role: collaborator

NCT02660463Unknown

Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany

Role: lead

NCT01498731Not ApplicableCompleted

Effect of the Biomarker Copeptin in Managing Patients With Suspected Acute Coronary Syndrome (ACS)

Role: collaborator

All 14 trials loaded